natgillin/translations-raw huggingface dataset:
Use only accordingly to the benefit/risk assessment by the responsible veterinarian.
Zdravilo uporabite le v skladu z oceno korist/tveganje odgovornega veterinarja .
Bravecto is a chewable tablet and is well accepted by most dogs.
Bravecto je žvečljiva tablet in jo večina psov dobro sprejme.
1210 Vienna
1210 Dunaj
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
Podrobne informacije o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) (http://www.ema.europa.eu/.)
The major route of elimination is the excretion of unchanged fluralaner in faeces (~90% of the dose).
Pomembnejši način eliminacije je izločanje nespremenjenega fluralanerja v fecesu (~90% odmerka).
Intervet UK Limited Walton Manor, Walton, Milton Keynes, Buckinghamshire, MK7 7AJ UNITED KINGDOM
Intervet UK Limited Walton Manor, Walton, Milton Keynes, Buckinghamshire, MK7 7AJ Združeno kraljestvo
Convulsions and lethargy has been reported very rarely in spontaneous reports.
O konvulzijah in letargiji so poročali zelo redko v spontanih poročilih.
People with a sensitive skin or known allergy in general e.g. to other veterinary medicinal products of this type should handle the veterinary medicinal product as well as treated animals with caution.
Ljudje z občutljivo kožo ali znano alergijo na splošno, npr. na druga zdravila za uporabo v veterinarski medicini tega tipa morajo z zdravili za uporabo v veterinarski medicini in z zdravljenimi živalmi ravnati previdno.
Incompatibilities: None known.
Inkompatibilnosti: Niso znane.
No treatment-related clinical signs were observed.
Z zdravljenjem povezanih kliničnih znakov niso opazili.
Major incompatibilities: None known.
Glavne inkompatibilnosti: Niso znane.
If you notice any side effects, even those not already listed in this package leaflet or you think the medicine has not worked, please inform your veterinary surgeon.
Če opazite kakršne koli resne stranske učinke, tudi tiste, ki niso navedeni v tem navodilu za uporabo ali mislite, da zdravilo ni delovalo, obvestite svojega veterinarja.
Light to dark brown tablet with a smooth or slightly rough surface and circular shape.
Svetla do temno rjava tableta z gladko ali rahlo grobo površino okrogle oblike.
Do not wash or allow the dog to become immersed in water or swim in water courses within 3 days after treatment.
Ne umivajte psa oz. ne dovolite psu, da se kopa ali plava v vodi 3 dni po zdravljenju.
Do not allow recently treated animals to groom each other.
Ne dovolite ravnokar zdravljenim mačkam da negujejo ena drugo.
The cap will stay on the pipette; it is not possible to remove it.
Zaporka bo ostala na kapalki; ni je mogoče odstraniti.
Fluralaner is systemically distributed and reaches the highest concentrations in fat, followed by liver, kidney and muscle.
Fluralaner se sistemsko porazdeli in doseže najvišje koncentracije v maščobi, nato sledijo jetra, ledvice in mišice.
This product is for topical use and should not be administered orally.
To zdravilo je za lokalno uporabo in se ne sme dajati peroralno.
In case of spillage onto, for example table or floor surfaces, remove excess product using paper tissue and clean the area with detergent.
V primeru razlitja, na primer po mizi ali po tleh, poberite odvečno zdravilo s papirnati brisačo in očistite površino z detergentom.
Intervet Productions Rue de Lyons 27460 Igoville FRANCE
Kožni nanos, raztopina: Intervet Productions Rue de Lyons 27460 Igoville Francija
Convulsions and lethargy has been reported very rarely in spontaneous (pharmacovigilance) reports.
O krčih in letargiji so poročali zelo redko v spontanih (farmakovigilančnih) poročilih.
Read package leaflet for full user safety information.
Za popolne varnostne informacije preberite navodilo za uporabo.
Do not use directly on skin lesions.
Ne nanašajte neposredno na poškodovano kožo.
If skin contact does occur, wash the affected area immediately with soap and water.
Če se pride do stika s kožo, prizadeto območje takoj sperite z milom in vodo.
Wear gloves when handling and administering this product.
Pri rokovanju in nanašanju zdravila uporabljajte rokavice.
Following oral administration, fluralaner is readily absorbed reaching maximum plasma concentrations within 1 day.
Po peroralnem dajanju se fluralaner zlahka absorbira in doseže maksimalno koncentracijo v plazmi v 1 dnevu.
The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
To zdravilo se lahko uporablja kot del strategije zdravljenje dermatitisa zaradi alergije na bolhe (FAD).
A plateau is seen in plasma between 7 and 63 days post administration, after which concentrations decline slowly.
Visok nivo je viden v krvni plazmi med 7. in 63. dnevom po dajanju, nakar koncentracija počasi pada.
In molecular on-target studies on insect GABA receptors of flea and fly, fluralaner is not affected by dieldrin resistance.
V molekularnih ciljanih študijah na GABA receptorjih bolhe in muhe fluralanerja ne prizadene odpornost na dieldrin.
In in vitro bio-assays, fluralaner is not affected by proven field resistances against amidines (tick), organophosphates (tick, mite), cyclodienes (tick, flea, fly), macrocyclic lactones (sea lice), phenylpyrazoles (tick, flea), benzophenyl ureas (tick), pyrethroids (tick, mite) and carbamates (mite).
V in vitro biotestih na fluralaner ne vpliva dokazana odpornost na amidine (klop), organofosfate (klop, pršica), ciklodiene (klop, bolha, muha), makrociklične laktone (morske uši), fenilpirazole (klop, bolha), benzofenil uree (klop), piretroide (klop, pršica) in karbamate (pršica).
Sodium lauryl sulfate Disodium embonate monohydrate Magnesium stearate Aspartame
Natrijev lavrilsulfat Dinatrijev embonat monohidrat Magnezijev stearat Aspartam
and Rhipicephalus sanguineus) and fleas (Ctenocephalides spp.)
Rhipicephalus sanguineus) in bolham (Ctenocephalides spp.)
Intervet GesmbH Siemensstrasse 107 1210 Vienna AUSTRIA
Žvečljiva tableta: Intervet GesmbH Siemensstrasse 107 1210 Dunaj Avstrija
The dog should be observed during administration to confirm that the tablet is swallowed.
Psa je treba opazovati, da vidite, da je tableto pogoltnil.
Step 3: Squeeze the pipette gently and apply the entire contents directly to the dog's skin in one (when volume is small) or several spots along the dog's dorsal line from the shoulder to the base of the tail.
Tretji korak: Rahlo stiskajte merilno kapalko in nanesite njeno celotno vsebino neposredno na kožo na eno (če je volumen majhen) ali več mestih vzdolž hrbtenice od ramen do korena repa.
on the cat.
pri mačkah.
It is efficacious against ticks (Ixodes spp.)
Učinkovit je proti klopom (Ixodes spp.)
It is efficacious against ticks (Ixodes spp., Dermacentor spp.
Učinkovit je proti klopom (Ixodes spp., Dermacentor spp.
Soya-bean oil
Sojino olje
Manufacturer responsible for batch release: Intervet GesmbH
Proizvajalec, odgovoren za sproščanje serij: Intervet GesmbH
The sachets should only be opened immediateley prior to use.
Vrečke odprite le neposredno pred uporabo.
Date of first authorisation: 11/02/2014
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet: 11/02/2014
Step 3: Squeeze the pipette gently and apply the entire contents directly to the cat's skin.
Tretji korak: Narahlo stiskajte merilno kapalko in nanesite njeno celotno vsebino neposredno na kožo.
Parasites need to start feeding on the host to become exposed to fluralaner; therefore the risk of the transmission of parasite borne diseases cannot be excluded.
Paraziti se morajo začeti hraniti na gostitelju, da so izpostavljeni fluralanerju, zato tveganja prenašanja bolezni, ki jih prenašajo paraziti, ni mogoče izključiti.
Administer Bravecto chewable tablets at or around the time of feeding.
Bravecto tableto dajte ob času hranjenja ali približno takrat.
For optimal control of tick infestation, the timing of retreatment depends on the tick species.
Za optimalni nadzor infestacije s klopi je čas ponovnega zdravljenja odvisen od vrste klopov.
Hypersensitivity reactions in humans have been reported.
Pri ljudeh so poročali o preobčutljivostnih reakcijah.
Bodyweight of dog (kg)
Telesna teža psa (kg)
The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see contraindications, section 4.3).
Zdravila ne smejo uporabljati osebe s preobčutljivostjo za učinkovino ali katerokoli pomožno snov (glejte Kontraindikacije, poglavje 4.3).
1 chewable tablet 2 chewable tablets 4 chewable tablets
VELIKOST PAKIRANJA 1 žvečljiva tableta 2 žvečljivi tableti 4 žvečljive tablete
Strength and number of tablets to be administered
Jakost in število tablet, ki jih je treba dati
Step 1: Immediately before use, open the sachet and remove the pipette.
Prvi korak: Neposredno pred uporabo odprite vrečko in izvlecite merilno kapalko.
Incubation of fluralaner in the presence of carprofen or warfarin in dog plasma at maximum expected plasma concentrations did not reduce the protein binding of fluralaner, carprofen or warfarin.
Inkubacija fluralanerja v prisotnosti karprofena ali varfarina v plazmi psa pri največjih pričakovanih plazemskih koncentracijah ni zmanjšala vezave fluralanerja, karprofena ali varfarina na beljakovine.
Avoid the application of more than 1 ml of solution at any one spot as it could cause some of the solution to run or drip off the dog.
Ne nanašajte več kot 1 ml raztopine na posamezno mesto, ker bi je lahko nekaj steklo ali odkapljalo s psa.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton Box
PODATKI NA ZUNANJI OVOJNINI KARTONSKA ŠKATLA
Fluralaner is a potent inhibitor of parts of the arthropod nervous system by acting antagonistically on ligand-gated chloride channels (GABA-receptor and glutamate-receptor).
Fluralener je močan inhibitor delov živčnega sistema artropodov s svojim antagonističnim delovanjem na ligand odvisne kloridne kanal (GABA receptor in receptor glutamata).
Cardboard box with 1 aluminium foil blister sealed with PET aluminium foil lid stock containing 1, 2 or 4 chewable tablets.
Kartonska škatla z 1 aluminijastim pretisnim omotom, zavarjenim s prevleko PET aluminijasta folija, ki vsebuje 1, 2 ali 4 žvečljive tablete.
Keep the pipette in the sachet until use.
Merilno kapalko hranite v vrečki do uporabe.
The following other signs shortly after administration were uncommonly observed: apathy/tremors/anorexia (0.9% of treated cats) or vomiting/hypersalivation (0.4% of treated cats).
Drugi znaki, ki so bili občasno opaženi kratek čas po dajanju zdravila, so: apatija/tresenje/neješčnost (0,9% zdravljenih mačk) ali bruhanje/povečano slinjenje (0,4 % zdravljenih mačk).
Marketing authorisation holder: Intervet International B. V.
Imetnik dovoljenja za promet z zdravilom: Intervet International B. V.
Treatment schedule:
Shema zdravljenja
Newly emerged fleas on a dog are killed before viable eggs are produced.
Bolhe, ki se na novo pojavijo na psih, so ubite, preden proizvedejo za življenje sposobna jajčeca.
Pharmacotherapeutic group: Ectoparasiticides for systemic use ATCvet code: QP53B E02
Farmakoterapevtska skupina: Učinkovine proti ektoparazitom za sistemsko zdravljenje Oznaka ATC vet: QP53B E02
Unchanged fluralaner is excreted in feces and to a very low extent in urine.
Nespremenjen fluralaner se izloči z fecesom in v zelo majhnem delu z urinom.
Oral uptake of the product at the maximum recommended dose of 93 mg fluralaner/kg body weight was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration.
Peroralni vnos največjega priporočenega odmerka (93 mg fluralanerja/kg telesne teže) so mačke dobro prenašale, z izjemo nekaj samoomejevanega slinjenja in kašljanja ali bruhanja neposredno po dajanju.
Each carton box contains 1 or 2 pipettes.
V vsaki kartonski škatli sta 1 ali 2 merlni kapalki.
In the absence of available data, this veterinary medicinal product should not be used on kitten less than 11 weeks old and /or cats weighing less than 1.2 kg.
Ker ni ustreznih podatkov, se to zdravilo za uporabo v veterinarski medicini ne sme uporabljati za mladiče mlajše od 11 tednov starosti in/ali za mačke, ki tehtajo manj kot 1,2 kg.
Oral uptake of the product at the maximum recommended dose was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration.
Peroralni vnos največjega priporočenega odmerka so mačke dobro prenašale, z izjemo samo omejevanega slinjenja in kašljanja ali bruhanja neposredno po dajanju.
Fluralaner is readily absorbed from the topical administration site into the hair, skin and subjacent tissues, from where it is slowly absorbed into the vascular system.
Po tlokalnem dajanju se fluralaner zlahka absorbira iz mesta nanosa v dlako, kožo in pod njo ležeča tkiva, od koder se počasi absorbira v krvni obtok.
Unit dose pipette made of laminated aluminium/polypropylene foil closed with an HDPE cap and packed in a laminated aluminium foil sachet.
Kapalka z enoto odmerka je narejena iz laminirane aluminijasto/polipropilenske folije, zaprta s HDPE zaporko in pakirana v vrečko iz laminirane aluminijaste folije.
Each ml contains 280 mg fluralaner.
1 ml vsebuje fluralaner 280 mg.
Wash hands thoroughly with soap and water immediately after use of the product.
Takoj po uporabi zdravila si roke dobro umijte z milom in vodo.
The product should not be administered at intervals shorter than 8 weeks as the safety for shorter intervals has not been tested.
Zdravilo se ne sme dajati v razmikih, krajših od 8 tednov, ker varnost za krajše razmike ni bila testirana.
and fleas (Ctenocephalides spp.)
(Ctenocephalides spp.)
Place the pipette tip on the base of the skull of the cat.
Nastavite vrh merilne kapalke na kožo na spodnji del lobanje mačke.
CLINICAL PARTICULARS 4.1 Target species
KLINIČNI PODATKI 4.1 Ciljne živalske vrste Psi.
Lot: {number}
Lot{številka}
Some marbling, speckles or both may be visible.
Včasih je marmorina ali ima majhne lise ali oboje.
The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see section Contraindications).
Zdravila ne smejo uporabljati osebe s preobčutljivostjo za učinkovino ali katerokoli pomožno snov (glejte poglavje Kontraindikacije).
Safety was demonstrated in breeding, pregnant and lactating animals treated with overdoses of up to 3 times the maximum recommended dose.
Varnost je bila dokazana pri živalih za vzrejo in pri živalih v času brejosti in laktacije, ki so jim dajali odmerke, ki so bili do 3krat večji od največjega priporočenega odmerka.
Fluralaner is highly bound to plasma proteins and might compete with other highly bound active substances such as non-steroidal anti-inflammatory drugs (NSAIDs) and the coumarin derivative warfarin.
Fluralaner se močno veže na plazemske beljakovine in lahko tekmuje z drugimi močno vezanimi učinkovinami, kot so nesteroidna protivnetna zdravila (NSAID), in kumarinski derivat varfarin.
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports)
Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (neželeni učinki se pokažejo pri več kot 1 od 10 zdravljenih živali) - pogosti (pri več kot 1, toda manj kot 10 živali od 100 zdravljenih živali) - občasni (pri več kot 1, toda manj kot 10 živali od 1.000 zdravljenih živali) - redki (pri več kot 1, toda manj kot 10 živali od 10.000 zdravljenih živali) - zelo redki (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri.
for small cats 1.2 - 2.8 kg for medium-sized cats >2.8 - 6.25 kg for large cats >6.25 - 12.5 kg
za majhne mačke 1,2 - 2,8 kg za srednje velike mačke >2,8 - 6,25 kg za velike mačke >6,25 - 12,5 kg
Care should be taken to avoid contact with the eyes of the animal.
Paziti je treba, da zdravilo za uporabo v veterinarski medicini ne pride v oči živali.
Fluralaner is readily systemically absorbed from the topical administration site, reaching maximum concentrations in plasma between 3 and 21 days after administration.
Po tlokalnem dajanju se fluralaner zlahka absorbira iz mesta nanosa in doseže maksimalno koncentracijo v krvni plazmi med 3. in 21. dnevom po dajanju.
Cap does not come off.
Zaporka se ne da odstraniti.
Mild and transient gastrointestinal effects such as diarrhoea, vomiting, inappetence, and drooling were commonly observed in clinical trials (1.6% of treated dogs).
Blagi in prehodni gastrointestinalni učinki, kot na primer diareja, bruhanje, pomanjkanje teka in slinjenje so bili pogosto opaženi med kliničnimi testiranji ( 1,6 % zdravljenih psov).
The prolonged persistence and slow elimination from plasma (t1/2 = 21 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval.
Podaljšano zadrževanje in počasno izločanje iz plazme (t1/2 = 21 dni) in pomanjkanje ekstenzivnega metabolizma zagotavljajo učinkovite koncentracije fluralanerja v času med dvema odmerkoma.
In order to avoid contact, disposable protective gloves obtained with this product at the point of sale must be worn when handling and administering the product.
Da bi se izognili stiku, je pri rokovanju in dajanju zdravila treba nositi zaščitne rokavice za enkratno uporabo, ki so priložene izdelku ob nakupu.
The pipettes should be kept in the outer packaging to prevent solvent loss or moisture uptake.
Merilne kapalke hranite v zunanji ovojnini, da se ne izgublja vehikel in da se ne navzamejo vlage.
The prolonged persistence and slow elimination from plasma (t1/2 = 12 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval.
Podaljšano zadrževanje in počasno izločanje iz plazme (t1/2 = 12 dni) in pomanjkanje metabolizmazagotavljajo učinkovite koncentracije fluralanerja v času med dvema odmerkoma.
In the absence of available data, this veterinary medicinal product should not be used on puppies less than 8 weeks old and /or dogs weighing less than 2 kg.
Ker ni ustreznih podatkov, se to zdravilo za uporabo v veterinarski medicini ne sme uporabljati za mladiče do 8 tednov starosti oziroma za pse, ki tehtajo manj kot 2 kg.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo za uporabo v veterinarski medicini
Skin rashes tingling or numbness have been reported in a small number of individuals after skin contact.
Po stiku s kožo so pri manjšem številu posameznikov poročali o izpuščajih, mravljinčenju ali otrplosti kože.
For optimal control of flea infestation, the veterinary medicinal product should be administered at intervals of 12 weeks.
Za optimalni nadzor infestacije z bolhami je treba zdravilo za uporabo v veterinarski medicini dajati v 12-tedenskih razmikih.
In case of contact with the eyes, immediately rinse thoroughly with water.
Zdravilo lahko povzroči draženje oči.V kolikor pride zdravilo v stik z očmi, ga takoj temeljito sperite z vodo
0.4 ml 0.89 ml 1.79 ml 3.57 ml 5.0 ml
0,4 ml 0,89 ml 1,79 ml 3,57 ml
Strength and number of pipettes to be administered
Jakost in število kapalk, ki jih je treba dati
The safety of the veterinary medicinal product in breeding, pregnant and lactating dogs has been demonstrated.
Varnost zdravila za uporabo v veterinarski medicini pri psih za vzrejo, v obdobju brejosti in laktacije je bila dokazana.
Step 2: The cat should be standing or lying with its back horizontal for easy application.
Drugi korak: Mačka naj med nanašanjem stoji ali leži, hrbet pa naj bo vodoraven za lažji nanos.
The pipette should be held by the base or by the upper rigid portion below the cap in an upright position (tip up) for opening it.
Kapalko je treba držati za njeno bazo ali za trdi del pod zaporko v pokončnem položaju.
The onset of efficacy is within 12 hours for fleas (C. felis) and within 48 hours for ticks (I. ricinus).
Učinkovanje se začne v 12 urah na bolhe (C. felis) in v 48 urah na klope (I. ricinus).
The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
Varnost zdravila za uporabo v veterinarski medicini v obdobju brejosti in laktacije ni bila dokazana.
Diethyltoluamide (DEET) Acetone
Seznam pomožnih snovi dimetilacetamid glikofurol dietiltoluamid (DEET) aceton
Bravecto 112.5 mg (2-4.5 kg) Bravecto 250 mg (>4.5 -10 kg) Bravecto 500 mg (>10 -20 kg) Bravecto 1,000 mg (>20 -40 kg) Bravecto 1,400 mg (>40 -56 kg) fluralaner
Bravecto 112,5 mg (2-4,5 kg) Bravecto 250 mg (>4.5-10 kg) Bravecto 500 mg (>10-20 kg) Bravecto 1000 mg (>20-40 kg) Bravecto 1400 mg (>40-56 kg)
For cats above 12.5 kg body weight, use a combination of two pipettes that most closely matches the body weight.
Za mačke s telesno težo nad 12,5 kg uporabite kombinacijo dveh kapalk, ki najbolj ustreza telesni teži.
Place the pipette tip vertically against the skin between the shoulder blades of the dog.
Konico merilne kapalke postavite navpično na kožo med lopaticama.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Datum zadnjega podaljšanja dovoljenja za promet:
Fluralaner was well tolerated in Collies with a deficient multidrug-resistance-protein 1 (MDR1 -/-) following single oral administration at 3 times the maximum recommended dose (168 mg/kg bodyweight).
Fluralaner so dobro prenašali koliji z nezadostnim MDR 1 -/- po enkratnem peroralnem dajanju 3krat večjega odmerka od priporočenega (168 mg/kg telesne teže).
Step 2: The dog should be standing or lying with its back horizontal during application.
Drugi korak: Pes naj med dajanjem stoji ali leži, hrbet pa naj bo vodoraven.
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer The NETHERLANDS
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer NIZOZEMSKA
For dogs above 56 kg bodyweight, use a combination of two tablets that most closely matches the bodyweight.
Za pse s telesno težo nad 56 kg uporabite kombinacijo dveh tablet, ki se najbolj približa telesni teži.
For dogs above 56 kg body weight, use a combination of two pipettes that most closely matches the body weight.
Za pse s telesno težo nad 56 kg uporabite kombinacijo dveh kapalk, ki najbolj ustreza telesni teži.
The veterinary medicinal product was well tolerated in Collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose (168 mg/kg bodyweight).
Zdravilo za uporabo v veterinarski medicini so dobro prenašali koliji z nezadostnim MDR 1 -/- po enkratnem peroralnem dajanju 3krat večjega odmerka od priporočenega (168 mg/ kg telesne teže).
The veterinary medicinal product was well tolerated in collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose.
Zdravilo za uporabo v veterinarski medicini so dobro prenašali koliji z nezadostnim MDR 1 -/- po enkratnem oralnem dajanju 3krat večjega odmerka od priporočenega.
on the dog.
na psih.
EU/2/13/158/018-019 112.5 mg EU/2/13/158/022-023 250 mg EU/2/13/158/026-027 500 mg
EU/2/13/158/022-023 250 mg EU/2/13/158/026-027 500 mg
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer Niozozemska
For the treatment of tick and flea infestations on dogs.
Za zdravljenje infestacije z bolhami in klopi pri psih.
The product should be applied on cats up to 6.25 kg body weight in one spot at the base of the skull and in two spots on cats greater than 6.25 kg bodyweight.
Zdravilo dajte mačkam, ki tehtajo do 6,25 kg,na eno mesto oz. na dve mesti mačkam, ki tehtajo več kot 6,25 kg na spodnji del lobanje.